Navigation Links
Biopharma Company UCB Unveils 40 Deserving 2010 Family Epilepsy Scholarship Recipients
Date:11/9/2010

ATLANTA, Nov. 9, 2010 /PRNewswire/ -- Today, UCB, Inc. celebrates the academic success of the 2010 UCB Family Epilepsy Scholarship recipients.  Over the past 6 years, UCB has awarded more than 200 scholarships, totaling over $1 million, to people whose lives have been directly affected by epilepsy, including those with epilepsy, their caregivers and family members.  Epilepsy is a common neurological condition that can affect anyone at anytime.  In the United States, 1 in 100 people are living with epilepsy.

"It is inspiring to see that year after year UCB recognizes the dreams of people affected by epilepsy and supports these individuals in accomplishing their academic aspirations," said Brien Smith, MD, Henry Ford Hospital, Neurology.

This year, 40 recipients were selected from a pool of nearly 800 applicants. UCB awarded 30 scholarships to people living with epilepsy and 10 scholarships to family members or caregivers of someone living with epilepsy.  Each recipient will receive a scholarship of $5,000 for tuition at colleges, graduate schools and technical schools across the country.  Applicants were considered based on their application, personal essay, letters of recommendation and their determination to live beyond the boundaries of epilepsy.

This year's recipients will be honored on the UCB Family Epilepsy Scholarship Facebook page.  To see photos and quotes from the 2010 recipients, read updates from past scholarship recipients and learn more about the UCB Family Epilepsy Scholarship Program™, please go to Facebook.com/UCBEpilepsyScholarship.  

2010 Scholarship Recipients and Their Selected Learning Institution:Emerald Allen

Concordia Lutheran UniversityKamell Ean Alston

West Chester UniversityCourtney Barringtine

Howard UniversityBeth Barton

Roosevelt UniversityAshley Breedlove

Midwestern State UniversityTravis Brown

Bowling Green Technical CollegeDalton Burghardt

California State University ChicoMadeleine Clifton

James Madison UniversityErin Cline

Glen Oaks Community CollegeDanielle DellaVella

Whitworth UniversityKristen Emerson

University of ConnecticutKaren Escobedo

University of California RiversideTanya Evans

Youngstown State UniversitySamuel Fazioli

Northeastern UniversityClaire Fons

University of Wisconsin MilwaukeeDai Quan Garner

Wesley CollegeDeborah Gunn

National UniversityCarrie Harpole

Henderson Community CollegePaul Anthony Henderson Jr.

University of South CarolinaAndrew Hibbitt

Florida Gulf Coast UniversityEmma Himpelmann

Kendall CollegeAaron Hoover

University of Southern IndianaEliza Jacobs-Brichford

Ithaca CollegeKatherine Japp

University of Texas, BrownsvilleAmanda Johnson

University of Pittsburgh Shelley Kays

Community College of MorrisTim Kelly

Central Michigan UniversityHannah Nicole Lawrence

Hinds Community CollegeMaureen Mahon

St. Louis UniversityEmmanuel Marrero

University of ToledoAmanda Mills

Goldey-Beacom CollegeLaKeisha Parnell

Atlanta Christian CollegeAshlin Phelps

Whitworth UniversityChristian Profitt

Midway CollegeAllison Rapsas

American Musical and Dramatic Academy Patrick Sheeran

George Mason UniversityKaitlyn Votel

St. Catherine UniversityLauren Wilson

Seattle UniversitySelena Winter

Adelphi UniversityAbout Epilepsy Epilepsy is a chronic neurological disorder affecting approximately 50 million people worldwide and three million people in the U.S.—making it more common than multiple sclerosis and Parkinson's disease combined. It is caused by abnormal, excessive electrical discharges of the nerve cells, or neurons, in the brain. Epilepsy is characterized by a tendency to have recurrent seizures and defined by two or more unprovoked seizures. There are many different seizure types and epileptic syndromes. Roughly 20-30 percent of people living with epilepsy have either uncontrolled seizures or significant side effects secondary to medication. This highlights the ongoing need for the development of new AEDs. For more information about epilepsy, visit www.EpilepsyAdvocate.com.

About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,000 people in about 40 countries, the company generated revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).

The UCB Family Epilepsy Scholarship Program™ is a trademark of the UCB group of companies.

Further InformationAndrea LevinSenior Manager, Communications & PR, CNS, UCB, Inc.T 770.970.8352M 404.483.7329Andrea.Levin@ucb.comLaura FinleyCooney/Waters GroupT 212.886.2258LFinley@cooneywaters.com
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Inspiration Biopharmaceuticals Awarded Two Grants Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
3. Cypin Production Announces Launch of U.S./China BioPharma Conference:
4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
5. Access Pharmaceuticals Signs Agreement With Leading Biopharmaceutical Company to Develop CobOral™ Formulation of Widely-Marketed Injectable
6. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
7. GENFIT Selected by Windhover for the 2011 Top Biopharma Projects To Watch
8. Inspiration Biopharmaceuticals OBI-1 Receives Orphan Drug Designation in Europe
9. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
10. Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
11. Laureate Pharma Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017  Novartis announced today that the ... the company,s Biologics License Application (BLA) filing and ... chimeric antigen receptor T cell (CAR-T) therapy, in ... patients with B-cell acute lymphoblastic leukemia (ALL). This ... a CAR-T. The priority review designation is expected ...
(Date:3/29/2017)... DUBLIN , Mar. 29, 2017 Research and ... Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast" ... ... 2021 from its current market size in 2016. The Untapped Proton Therapy ... than 1 Billion USD in 2016. Proton Therapy plays ...
(Date:3/29/2017)...  Zynex (OTCQB: ZYXI), an innovative medical technology company specializing ... for pain management, stroke rehabilitation, cardiac monitoring and neurological ... 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. ... expects to file its 2016 full year financial results ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... , ... March 30, 2017 , ... Grass pollen is the main cause of hay ... the stuff. The season for grass pollen runs from May to July each year; with ... fever victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense ...
(Date:3/29/2017)... ... ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower program in 2009 ... have participated in the program every summer. The 2017 Serve, Learn, & Empower ... Visit http://www.ghana.yfiexperience.org to learn more. , “I have sent my daughter ...
(Date:3/29/2017)... ... 30, 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale ... for the remaining days of March, the price will be only $19.97. The EXOUS ... of just $10 (regular retail price $19.97). , The special promotional prices are to ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... IN (PRWEB) , ... March 29, 2017 , ... ... Study, this webinar provides insight into the challenges employers face in trying to ... complexity of managing employee benefits programs? Adding to the growing complexity, companies ...
Breaking Medicine News(10 mins):